Natural molecules or derivatives make up more than half of the current drugs on the market with applications to nearly every disease known to humans. Salicylic acid, morphine, cannabinoids and insulin are a few examples. Our specialty is in producing these, and new targets, using a fast and scalable platform based on engineered microbes.
We use the technologies from traditional and modern biology combined with computational analysis to develop our organisms at the fastest possible speed. This makes our platform faster and cheaper than chemical synthesis or extraction from the natural source.
Location: Canada, Quebec, Montreal
Employees: 11-50
Total raised: $2.5M
Founded date: 2014
Investors 3
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.10.2020 | - | $2.5M | - |
Mentions in press and media 7
| Date | Title | Description | Source |
| 20.04.2022 | How CBD biomanufacturing could make Europe change and win th... | By now, many have heard about Cannabidiol, better known as CBD, the non-psychoactive cannabinoid der... | tech.eu/20... |
| 23.10.2020 | Hyasynth completes key commercialization milestone for canna... | prnewswire... | |
| 07.10.2020 | Hyasynth: Biotech Startup First To To Bring Fermented CBD To... | 0 2 Mins Read Montreal-based biotechnology company Hyasynth has won the race to become the first to ... | greenqueen... |
| 20.03.2019 | Amyris teams up with LAVVAN to bring fermentation-derived CB... | The news follows a string of announcements from firms also developing platforms to biosynthesize can... | foodnaviga... |
| 13.03.2018 | Agtech Startups Aim to Help the CA Cannabis Market Stay in t... | Recreational use of cannabis became legal in the state of California on January 1, 2018, and before ... | agfunderne... |
| 13.10.2017 | The Future of Pharmaceutical Cannabis May Be Cultured, Not C... | Hyasynth Bio is a Montreal-based biotech startup that has developed a way to produce the active comp... | agfunderne... |
| - | How CBD biomanufacturing could make Europe change and win th... | By now, many have heard about Cannabidiol, better known as CBD, the non-psychoactive cannabinoid der... | tech.eu/20... |